Evan Kearns - 13 Feb 2023 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	COGT	Stock Option (Right to Buy)	Award	$0	+140,000		$0.000000	140,000	13 Feb 2023	Common Stock	140,000	$13.63	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This stock option shall vest in equal monthly installments over a four year period.